{
    "2015-04-15": [
        "Japan's RegImmune joins with Pfizer on Type 1 diabetes antigen candidate",
        "$PFE up 1.1% in PreM on release PALOMA-3 Trial for IBRANCE stopped early due to efficacy in patients w/ HR+ HER2: Metastatic Breast Cancer",
        "Palbociclib continues to be a bright spot for Pfizer R&D. Breast cancer study stopped early on efficacy"
    ]
}